BFLY vs. TMDX, SLNO, ENOV, LIVN, NVCR, WRBY, LMAT, CNMD, TNDM, and LQDA
Should you be buying Butterfly Network stock or one of its competitors? The main competitors of Butterfly Network include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Enovis (ENOV), LivaNova (LIVN), NovoCure (NVCR), Warby Parker (WRBY), LeMaitre Vascular (LMAT), CONMED (CNMD), Tandem Diabetes Care (TNDM), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry.
Butterfly Network vs.
Butterfly Network (NYSE:BFLY) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends.
TransMedics Group has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.
Butterfly Network has a beta of 2.48, indicating that its share price is 148% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500.
TransMedics Group has a net margin of 8.14% compared to Butterfly Network's net margin of -129.25%. TransMedics Group's return on equity of 18.74% beat Butterfly Network's return on equity.
Butterfly Network currently has a consensus target price of $3.00, indicating a potential upside of 25.26%. TransMedics Group has a consensus target price of $122.70, indicating a potential upside of 78.46%. Given TransMedics Group's higher possible upside, analysts clearly believe TransMedics Group is more favorable than Butterfly Network.
In the previous week, TransMedics Group had 48 more articles in the media than Butterfly Network. MarketBeat recorded 51 mentions for TransMedics Group and 3 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.61 beat TransMedics Group's score of 0.12 indicating that Butterfly Network is being referred to more favorably in the media.
37.8% of Butterfly Network shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 27.3% of Butterfly Network shares are owned by insiders. Comparatively, 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
TransMedics Group received 105 more outperform votes than Butterfly Network when rated by MarketBeat users. However, 70.00% of users gave Butterfly Network an outperform vote while only 58.95% of users gave TransMedics Group an outperform vote.
Summary
TransMedics Group beats Butterfly Network on 13 of the 19 factors compared between the two stocks.
Get Butterfly Network News Delivered to You Automatically
Sign up to receive the latest news and ratings for BFLY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Butterfly Network Competitors List
Related Companies and Tools
This page (NYSE:BFLY) was last updated on 3/28/2025 by MarketBeat.com Staff
